サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1711609

核医学/放射性医薬品市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、形態、材料タイプ、プロセス、機器

Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Form, Material Type, Process, Equipment

出版日
ページ情報
英文 352 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
核医学/放射性医薬品市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、形態、材料タイプ、プロセス、機器
出版日: 2025年04月23日
発行: Global Insight Services
ページ情報: 英文 352 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

核医学／放射性医薬品市場は、2024年の48億米ドルから2034年までには126億米ドルに拡大し、約10.1％のCAGRで成長すると予測されています。同市場は、診断と治療のための放射性物質の生産と応用を包含します。PETやSPECTのような画像診断技術や、腫瘍学や心臓病学における治療用途が含まれます。この市場を牽引しているのは、分子イメージング技術の進歩、がん罹患率の増加、非侵襲的手技に対する需要の高まりであり、標的放射性医薬品の技術革新の機会を浮き彫りにしています。

市場概要

核医学/放射性医薬品市場は、多様なセグメントによって特徴付けられますが、中でも診断用放射性医薬品は、主に疾患の早期発見と管理において極めて重要な役割を果たすため、市場をリードしています。このセグメントの優位性は、PETやSPECTのような画像技術の進歩と相まって、がんや心血管障害のような慢性疾患の有病率が増加していることに起因しています。治療用放射性医薬品は、標的放射性同位元素治療が最小限の副作用で有望な治療手段を提供する腫瘍学を中心に急速に普及しています。新興のサブセグメントの中でも、セラノスティクスは診断と治療の機能を統合し、個別化された治療戦略を提供することで、市場に革命を起こそうとしています。さらに、神経学、特にアルツハイマー病やパーキンソン病の研究における放射性医薬品の応用が増加していることは、市場に大きな影響を与える可能性を強調しています。放射性同位体製造における継続的な技術革新と新規放射性医薬品に対する規制当局の支援が市場の成長をさらに後押しし、利害関係者に有利な機会をもたらします。

市場セグメンテーション
タイプ 診断用放射性医薬品、治療用放射性医薬品
製品 テクネチウム-99m、ヨウ素131、フッ素18、ルテチウム177、イットリウム90、ガリウム68、ラジウム223
サービス ラジオアイソトープ製造、ラジオファーマシーサービス、核イメージングサービス
技術 単一光子放射断層撮影法（SPECT）、陽電子放射断層撮影法（PET）、ハイブリッドイメージング
用途 腫瘍学、心臓病学、神経学、内分泌学、消化器病学、感染症学、腎臓病学
エンドユーザー 病院、画像診断センター、学術・研究機関
形態 液体、カプセル
材料タイプ 有機化合物、無機化合物
製造プロセス サイクロトロン製造、原子炉製造
機器 ガンマカメラ、PETスキャナー、SPECTスキャナー

核医学・放射性医薬品市場では、慢性疾患の増加や早期かつ精密な診断技術に対する需要の高まりにより、診断用放射性医薬品が大きなシェアを占めています。治療用放射性医薬品も、標的がん治療や個別化医療アプローチの進歩を反映して牽引力を増しています。北米は強固なヘルスケアインフラと重要な研究活動により市場をリードしていますが、アジア太平洋地域はヘルスケア投資の拡大と核医学応用の認知度向上により急成長を遂げています。

競合情勢はSiemens Healthineers、GE Healthcare、Cardinal Healthなどの主要企業が、市場での地位を高めるために戦略的提携や技術革新に積極的に取り組んでいることが特徴です。特に米国と欧州の規制環境は厳しさを増しており、厳格な安全性と有効性の基準への準拠が求められています。今後については、放射性医薬品製造技術の進歩や、腫瘍学・循環器学における核医学応用の拡大により、市場は大幅な成長を遂げる見通しです。しかし、新興国市場や新たな治療用途から生じる大きな成長機会はあるものの、高い開発コストや規制当局の承認プロセスなどの課題は依然として残っています。

主要動向と促進要因：

核医学・放射性医薬品市場は、画像診断技術の進歩と慢性疾患の蔓延に後押しされ、力強い成長を遂げています。主な動向には、画像診断ソリューションへの人工知能の統合による診断精度と効率の向上が含まれます。また、特定の疾患をターゲットとする新規放射性医薬品の開発も牽引役となっており、個別化治療の選択肢を提供し、患者の転帰を改善しています。

市場促進要因としては、非侵襲的診断技術に対する需要の高まりや、慢性疾患に罹患しやすい高齢者人口の増加が挙げられます。さらに、がん研究や核医学を推進する政府の取り組みが市場拡大を後押ししています。PET/CTやSPECT/CTなどのハイブリッド画像診断システムの採用が増加していることも、包括的な診断洞察を提供することで成長をさらに促進しています。

未開拓の市場、特にヘルスケアインフラが発展しつつある新興国市場にビジネスチャンスが生まれつつあります。革新的で費用対効果の高い放射性医薬品を生み出すために研究開発に投資している企業は、市場シェアを獲得するのに有利な立場にあります。さらに、学術機関と業界プレイヤーのコラボレーションが核医学の進歩を促進し、この分野の将来の成長と革新への道を開いています。

抑制要因と課題：

核医学/放射性医薬品市場には、いくつかの重大な抑制要因と課題があります。まず、厳しい規制要件が大きな課題となっています。新規放射性医薬品の承認プロセスは複雑で時間がかかるため、市場参入が遅れることが多いです。さらに、放射性医薬品の製造コストが高いため、特に開発途上地域では、入手しやすさや購入しやすさが制限されます。もう一つの課題は、熟練した専門家の不足です。放射性医薬品の取り扱いや投与に必要な専門知識は不足しており、サービス提供に影響を及ぼしています。さらに、放射性医薬品は半減期が短いなどサプライチェーンが複雑なため、効率的なロジスティクスが必要となりますが、これを維持するのは困難です。最後に、安全プロトコルが進歩しているにもかかわらず、放射線被ばくに対する人々の認識や安全性への懸念が、市場の受容を妨げています。これらの課題は、核医学と放射性医薬品の成長と幅広い普及の妨げとなっています。

目次

第1章 核医学/放射性医薬品市場の概要

  • 調査目的
  • 核医学/放射性医薬品市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年と通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 核医学/放射性医薬品市場の展望

  • 核医学/放射性医薬品市場のセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 核医学/放射性医薬品市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • ケーススタディ分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析
  • 最近の動向

第6章 核医学/放射性医薬品市場規模

  • 核医学/放射性医薬品の市場規模：金額別
  • 核医学/放射性医薬品の市場規模：数量別

第7章 核医学/放射性医薬品市場：タイプ別

  • 市場概要
  • 診断用放射性医薬品
  • 治療用放射性医薬品
  • その他

第8章 核医学/放射性医薬品市場：製品別

  • 市場概要
  • テクネチウム-99m
  • ヨウ素131
  • フッ素-18
  • ルテチウム-177
  • イットリウム-90
  • ガリウム-68
  • ラジウム-223
  • その他

第9章 核医学/放射性医薬品市場：サービス別

  • 市場概要
  • 放射性同位元素製造
  • ラジオファーマシーサービス
  • 核医学イメージングサービス
  • その他

第10章 核医学/放射性医薬品市場：技術別

  • 市場概要
  • 単一光子放出コンピュータ断層撮影法（SPECT）
  • 陽電子放射断層撮影法（PET）
  • ハイブリッドイメージング
  • その他

第11章 核医学／放射性医薬品市場：用途別

  • 市場概要
  • 腫瘍学
  • 循環器
  • 神経学
  • 内分泌学
  • 消化器内科
  • 感染症学
  • 腎臓内科
  • その他

第12章 核医学／放射性医薬品市場：エンドユーザー別

  • 市場概要
  • 病院
  • 画像診断センター
  • 学術・研究機関
  • その他

第13章 核医学／放射性医薬品市場：形態別

  • 市場概要
  • 液体
  • カプセル
  • その他

第14章 核医学/放射性医薬品市場：材料タイプ別

  • 市場概要
  • 有機化合物
  • 無機化合物
  • その他

第15章 核医学/放射性医薬品市場：プロセス別

  • 市場概要
  • サイクロトロン製造
  • 原子炉製造
  • その他

第16章 核医学／放射性医薬品市場：機器別

  • 市場概要
  • ガンマカメラ
  • PETスキャナー
  • SPECTスキャナー
  • その他

第17章 核医学/放射性医薬品市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東・アフリカ

第18章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第19章 企業プロファイル

  • Advanced Accelerator Applications
  • Jubilant Radiopharma
  • Curium Pharma
  • NorthStar Medical Radioisotopes
  • Shine Medical Technologies
  • Isotopia Molecular Imaging
  • ITM Isotopen Technologien Munchen
  • Eckert & Ziegler
  • Nordion
  • RadioMedix
  • Cyclopharm
  • Clarity Pharmaceuticals
  • Blue Earth Diagnostics
  • Progenics Pharmaceuticals
  • Navidea Biopharmaceuticals
  • Lantheus Holdings
  • Sofie Biosciences
  • Radiopharm Theranostics
  • Telix Pharmaceuticals
  • Cardinal Health Nuclear Pharmacy Services
目次
Product Code: GIS10340

Nuclear Medicine/Radiopharmaceuticals Market is anticipated to expand from $4.8 billion in 2024 to $12.6 billion by 2034, growing at a CAGR of approximately 10.1%. The market encompasses the production and application of radioactive substances for diagnosis and therapy. It involves imaging techniques like PET and SPECT, and therapeutic uses in oncology and cardiology. This market is driven by advancements in molecular imaging, increasing cancer prevalence, and a rising demand for non-invasive procedures, highlighting opportunities for innovation in targeted radiopharmaceuticals.

Market Overview

The Nuclear Medicine/Radiopharmaceuticals Market is characterized by a diverse array of segments, with diagnostic radiopharmaceuticals leading the charge, primarily due to their pivotal role in early disease detection and management. This segment's dominance is driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, coupled with advancements in imaging technologies like PET and SPECT. Therapeutic radiopharmaceuticals are rapidly gaining traction, particularly in oncology, where targeted radioisotope therapies offer promising treatment avenues with minimal side effects. Among emerging sub-segments, theranostics is poised to revolutionize the market by integrating diagnostic and therapeutic capabilities, providing personalized treatment strategies. Furthermore, the increasing application of radiopharmaceuticals in neurology, especially in Alzheimer's and Parkinson's disease research, underscores the potential for significant market impact. Continuous innovation in radioisotope production and regulatory support for novel radiopharmaceuticals further bolsters market growth, promising lucrative opportunities for stakeholders.

Market Segmentation
TypeDiagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals
ProductTechnetium-99m, Iodine-131, Fluorine-18, Lutetium-177, Yttrium-90, Gallium-68, Radium-223
ServicesRadioisotope Production, Radiopharmacy Services, Nuclear Imaging Services
TechnologySingle Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Hybrid Imaging
ApplicationOncology, Cardiology, Neurology, Endocrinology, Gastroenterology, Infectious Diseases, Nephrology
End UserHospitals, Diagnostic Imaging Centers, Academic and Research Institutes
FormLiquid, Capsule
Material TypeOrganic Compounds, Inorganic Compounds
ProcessCyclotron Production, Nuclear Reactor Production
EquipmentGamma Cameras, PET Scanners, SPECT Scanners

In the nuclear medicine and radiopharmaceuticals market, diagnostic radiopharmaceuticals hold a prominent share, driven by the increasing prevalence of chronic diseases and the rising demand for early and precise diagnostic techniques. Therapeutic radiopharmaceuticals are gaining traction as well, reflecting advancements in targeted cancer therapies and personalized medicine approaches. North America leads the market due to its robust healthcare infrastructure and significant research activities, while the Asia-Pacific region is witnessing rapid growth fueled by expanding healthcare investments and rising awareness of nuclear medicine applications.

The competitive landscape is marked by the presence of key players such as Siemens Healthineers, GE Healthcare, and Cardinal Health, which are actively engaged in strategic collaborations and technological innovations to enhance their market position. Regulatory environments, particularly in the United States and Europe, are becoming increasingly stringent, necessitating compliance with rigorous safety and efficacy standards. Looking ahead, the market is poised for substantial growth, driven by advancements in radiopharmaceutical production technologies and the expansion of nuclear medicine applications in oncology and cardiology. However, challenges such as high costs of development and regulatory approval processes remain, albeit with significant opportunities for growth arising from emerging markets and novel therapeutic applications.

Recent Developments:

The Nuclear Medicine/Radiopharmaceuticals Market has experienced noteworthy developments over the past three months. GE HealthCare announced a strategic partnership with NorthStar Medical Radioisotopes to advance the production of diagnostic and therapeutic radiopharmaceuticals, enhancing supply chain reliability and expanding product offerings. In a significant merger and acquisition move, Curium acquired IASON, a European leader in PET radiopharmaceuticals, to strengthen its position in the European market and broaden its product portfolio. Cardinal Health unveiled a new state-of-the-art radiopharmacy in the United States, aiming to improve the distribution efficiency of nuclear medicine products and meet the growing demand for radiopharmaceuticals. The European Medicines Agency approved a new radiopharmaceutical therapy developed by Telix Pharmaceuticals, marking a milestone for the company and expanding treatment options for prostate cancer. Lastly, Siemens Healthineers announced a collaboration with the University of Pennsylvania to develop innovative imaging technologies, focusing on enhancing the precision of nuclear medicine diagnostics. These developments underscore the sector's dynamic growth and the strategic maneuvers by key players to capitalize on emerging opportunities.

Key Trends and Drivers:

The nuclear medicine and radiopharmaceuticals market is experiencing robust growth, propelled by advancements in diagnostic imaging technologies and increasing prevalence of chronic diseases. Key trends include the integration of artificial intelligence in imaging solutions, enhancing diagnostic accuracy and efficiency. The development of novel radiopharmaceuticals targeting specific diseases is also gaining traction, offering personalized treatment options and improved patient outcomes.

Drivers of the market encompass the rising demand for non-invasive diagnostic techniques and the growing geriatric population, which is more susceptible to chronic conditions. Additionally, government initiatives promoting cancer research and nuclear medicine are bolstering market expansion. The increasing adoption of hybrid imaging systems, such as PET/CT and SPECT/CT, is further driving growth by providing comprehensive diagnostic insights.

Opportunities are emerging in untapped markets, particularly in developing regions where healthcare infrastructure is evolving. Companies investing in research and development to create innovative, cost-effective radiopharmaceuticals are well-positioned to capture market share. Furthermore, collaborations between academic institutions and industry players are fostering advancements in nuclear medicine, paving the way for future growth and innovation in the sector.

Restraints and Challenges:

The Nuclear Medicine/Radiopharmaceuticals Market encounters several significant restraints and challenges. Firstly, stringent regulatory requirements pose a substantial challenge. The approval process for new radiopharmaceuticals is complex and time-consuming, often delaying market entry. Additionally, high production costs for radiopharmaceuticals limit their accessibility and affordability, particularly in developing regions. Another challenge is the shortage of skilled professionals. The specialized knowledge required to handle and administer these substances is scarce, impacting service delivery. Furthermore, supply chain complexities, including the short half-life of radiopharmaceuticals, necessitate efficient logistics, which can be difficult to maintain. Lastly, public perception and safety concerns about radiation exposure hinder market acceptance, despite advancements in safety protocols. These challenges collectively impede the growth and broader adoption of nuclear medicine and radiopharmaceuticals.

Key Companies:

Advanced Accelerator Applications, Jubilant Radiopharma, Curium Pharma, North Star Medical Radioisotopes, Shine Medical Technologies, Isotopia Molecular Imaging, ITM Isotopen Technologien Munchen, Eckert & Ziegler, Nordion, Radio Medix, Cyclopharm, Clarity Pharmaceuticals, Blue Earth Diagnostics, Progenics Pharmaceuticals, Navidea Biopharmaceuticals, Lantheus Holdings, Sofie Biosciences, Radiopharm Theranostics, Telix Pharmaceuticals, Cardinal Health Nuclear Pharmacy Services

Sources:

World Nuclear Association, International Atomic Energy Agency (IAEA), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Society of Nuclear Medicine and Molecular Imaging (SNMMI), European Association of Nuclear Medicine (EANM), Radiological Society of North America (RSNA), American College of Radiology (ACR), National Institutes of Health (NIH), U.S. Department of Energy (DOE), Canadian Nuclear Safety Commission (CNSC), Australian Nuclear Science and Technology Organisation (ANSTO), Japan Atomic Energy Agency (JAEA), United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), International Conference on Radiopharmaceutical Sciences, World Congress of Nuclear Medicine and Biology, International Symposium on Radiopharmaceutical Chemistry, European Congress of Radiology, International Conference on Isotopes, International Atomic Energy Agency General Conference

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Nuclear Medicine/Radiopharmaceuticals Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Nuclear Medicine/Radiopharmaceuticals Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Form
  • 2.10 Key Highlights of the Market, by Material Type
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by Equipment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Form
  • 3.9 Market Attractiveness Analysis, by Material Type
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by Equipment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Nuclear Medicine/Radiopharmaceuticals Market Outlook

  • 4.1 Nuclear Medicine/Radiopharmaceuticals Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Nuclear Medicine/Radiopharmaceuticals Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Nuclear Medicine/Radiopharmaceuticals Market Size

  • 6.1 Nuclear Medicine/Radiopharmaceuticals Market Size, by Value
  • 6.2 Nuclear Medicine/Radiopharmaceuticals Market Size, by Volume

7: Nuclear Medicine/Radiopharmaceuticals Market, by Type

  • 7.1 Market Overview
  • 7.2 Diagnostic Radiopharmaceuticals
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Radiopharmaceuticals
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Nuclear Medicine/Radiopharmaceuticals Market, by Product

  • 8.1 Market Overview
  • 8.2 Technetium-99m
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Iodine-131
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fluorine-18
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Lutetium-177
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Yttrium-90
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Gallium-68
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Radium-223
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Nuclear Medicine/Radiopharmaceuticals Market, by Services

  • 9.1 Market Overview
  • 9.2 Radioisotope Production
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Radiopharmacy Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Nuclear Imaging Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Nuclear Medicine/Radiopharmaceuticals Market, by Technology

  • 10.1 Market Overview
  • 10.2 Single Photon Emission Computed Tomography (SPECT)
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Positron Emission Tomography (PET)
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Hybrid Imaging
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Nuclear Medicine/Radiopharmaceuticals Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cardiology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Neurology
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Endocrinology
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Gastroenterology
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Infectious Diseases
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Nephrology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Others
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region

12: Nuclear Medicine/Radiopharmaceuticals Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Diagnostic Imaging Centers
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Academic and Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Nuclear Medicine/Radiopharmaceuticals Market, by Form

  • 13.1 Market Overview
  • 13.2 Liquid
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Capsule
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Nuclear Medicine/Radiopharmaceuticals Market, by Material Type

  • 14.1 Market Overview
  • 14.2 Organic Compounds
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Inorganic Compounds
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Nuclear Medicine/Radiopharmaceuticals Market, by Process

  • 15.1 Market Overview
  • 15.2 Cyclotron Production
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Nuclear Reactor Production
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Nuclear Medicine/Radiopharmaceuticals Market, by Equipment

  • 16.1 Market Overview
  • 16.2 Gamma Cameras
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 PET Scanners
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 SPECT Scanners
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Nuclear Medicine/Radiopharmaceuticals Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Form
    • 17.2.9 North America Market Size and Forecast, by Material Type
    • 17.2.10 North America Market Size and Forecast, by Process
    • 17.2.11 North America Market Size and Forecast, by Equipment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Form
      • 17.2.9.8 United States Market Size and Forecast, by Material Type
      • 17.2.9.9 United States Market Size and Forecast, by Process
      • 17.2.9.10 United States Market Size and Forecast, by Equipment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Form
      • 17.2.10.8 Canada Market Size and Forecast, by Material Type
      • 17.2.10.9 Canada Market Size and Forecast, by Process
      • 17.2.10.10 Canada Market Size and Forecast, by Equipment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Form
    • 17.3.9 Europe Market Size and Forecast, by Material Type
    • 17.3.10 Europe Market Size and Forecast, by Process
    • 17.3.11 Europe Market Size and Forecast, by Equipment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Equipment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Form
      • 17.3.10.8 Germany Market Size and Forecast, by Material Type
      • 17.3.10.9 Germany Market Size and Forecast, by Process
      • 17.3.10.10 Germany Market Size and Forecast, by Equipment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Form
      • 17.3.11.8 France Market Size and Forecast, by Material Type
      • 17.3.11.9 France Market Size and Forecast, by Process
      • 17.3.11.10 France Market Size and Forecast, by Equipment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Form
      • 17.3.12.8 Spain Market Size and Forecast, by Material Type
      • 17.3.12.9 Spain Market Size and Forecast, by Process
      • 17.3.12.10 Spain Market Size and Forecast, by Equipment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Form
      • 17.3.13.8 Italy Market Size and Forecast, by Material Type
      • 17.3.13.9 Italy Market Size and Forecast, by Process
      • 17.3.13.10 Italy Market Size and Forecast, by Equipment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Form
      • 17.3.14.8 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.9 Netherlands Market Size and Forecast, by Process
      • 17.3.14.10 Netherlands Market Size and Forecast, by Equipment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Form
      • 17.3.15.8 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.9 Sweden Market Size and Forecast, by Process
      • 17.3.15.10 Sweden Market Size and Forecast, by Equipment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Form
      • 17.3.16.8 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.9 Switzerland Market Size and Forecast, by Process
      • 17.3.16.10 Switzerland Market Size and Forecast, by Equipment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Form
      • 17.3.17.8 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.9 Denmark Market Size and Forecast, by Process
      • 17.3.17.10 Denmark Market Size and Forecast, by Equipment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Form
      • 17.3.18.8 Finland Market Size and Forecast, by Material Type
      • 17.3.18.9 Finland Market Size and Forecast, by Process
      • 17.3.18.10 Finland Market Size and Forecast, by Equipment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Form
      • 17.3.19.8 Russia Market Size and Forecast, by Material Type
      • 17.3.19.9 Russia Market Size and Forecast, by Process
      • 17.3.19.10 Russia Market Size and Forecast, by Equipment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Equipment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Equipment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Form
      • 17.4.9.8 China Market Size and Forecast, by Material Type
      • 17.4.9.9 China Market Size and Forecast, by Process
      • 17.4.9.10 China Market Size and Forecast, by Equipment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Form
      • 17.4.10.8 India Market Size and Forecast, by Material Type
      • 17.4.10.9 India Market Size and Forecast, by Process
      • 17.4.10.10 India Market Size and Forecast, by Equipment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Form
      • 17.4.11.8 Japan Market Size and Forecast, by Material Type
      • 17.4.11.9 Japan Market Size and Forecast, by Process
      • 17.4.11.10 Japan Market Size and Forecast, by Equipment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Form
      • 17.4.12.8 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.9 South Korea Market Size and Forecast, by Process
      • 17.4.12.10 South Korea Market Size and Forecast, by Equipment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Form
      • 17.4.13.8 Australia Market Size and Forecast, by Material Type
      • 17.4.13.9 Australia Market Size and Forecast, by Process
      • 17.4.13.10 Australia Market Size and Forecast, by Equipment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Form
      • 17.4.14.8 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.9 Singapore Market Size and Forecast, by Process
      • 17.4.14.10 Singapore Market Size and Forecast, by Equipment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Form
      • 17.4.15.8 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.9 Indonesia Market Size and Forecast, by Process
      • 17.4.15.10 Indonesia Market Size and Forecast, by Equipment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Form
      • 17.4.16.8 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.9 Taiwan Market Size and Forecast, by Process
      • 17.4.16.10 Taiwan Market Size and Forecast, by Equipment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Form
      • 17.4.17.8 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.9 Malaysia Market Size and Forecast, by Process
      • 17.4.17.10 Malaysia Market Size and Forecast, by Equipment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Equipment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Form
    • 17.5.9 Latin America Market Size and Forecast, by Material Type
    • 17.5.10 Latin America Market Size and Forecast, by Process
    • 17.5.11 Latin America Market Size and Forecast, by Equipment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Form
      • 17.5.9.8 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.9 Brazil Market Size and Forecast, by Process
      • 17.5.9.10 Brazil Market Size and Forecast, by Equipment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Form
      • 17.5.10.8 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.9 Mexico Market Size and Forecast, by Process
      • 17.5.10.10 Mexico Market Size and Forecast, by Equipment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Form
      • 17.5.11.8 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.9 Argentina Market Size and Forecast, by Process
      • 17.5.11.10 Argentina Market Size and Forecast, by Equipment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Equipment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Equipment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Equipment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Form
      • 17.6.10.8 UAE Market Size and Forecast, by Material Type
      • 17.6.10.9 UAE Market Size and Forecast, by Process
      • 17.6.10.10 UAE Market Size and Forecast, by Equipment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Form
      • 17.6.11.8 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.9 South Africa Market Size and Forecast, by Process
      • 17.6.11.10 South Africa Market Size and Forecast, by Equipment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Equipment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Advanced Accelerator Applications
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Jubilant Radiopharma
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Curium Pharma
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 NorthStar Medical Radioisotopes
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Shine Medical Technologies
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Isotopia Molecular Imaging
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 ITM Isotopen Technologien Munchen
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Eckert & Ziegler
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Nordion
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 RadioMedix
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Cyclopharm
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Clarity Pharmaceuticals
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Blue Earth Diagnostics
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Progenics Pharmaceuticals
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Navidea Biopharmaceuticals
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Lantheus Holdings
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Sofie Biosciences
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Radiopharm Theranostics
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Telix Pharmaceuticals
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Cardinal Health Nuclear Pharmacy Services
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis